Selling pressure pushes Novartis stock lower in today's trading

Traders Union
All News
Financial News
Novartis slides 2.32% today to $147.38

Highlights

Novartis remains under short- and medium-term selling pressure while retaining long-term trend support above $142.
Key technical resistance is near $149 with downside support at $142, framing the likely consolidation range.
Indicators are mixed, but a high-probability scenario favors upward movement toward $151.88 unless sellers drive a break below $144.38.

Anton Kharitonov, expert at Traders Union, views the recent Novartis move with caution. He notes the asset is under short- and medium-term selling pressure, trading below its 20- and 50-day MAs. The lack of supportive news flow undermines sentiment and could limit upside potential. Momentum indicators are mixed, with weak trend strength and divergences adding to risk. "A decisive break below $144.38 would make a correction toward $142 likely — I see little support for optimism given the current technical and sentiment setup."

Viktoras Karapetjanc, expert at Traders Union, sees a constructive setup for Novartis. Despite the recent decline, he highlights that the price holds above the key 200-day MA, which underlines strong long-term demand. Technical structure favors bulls, as all major weekly indicators align for potential upward movement. A close above $149.00 could trigger a sustained rally toward $151.88. "I remain confident that Novartis will attract buyers and retest higher resistance zones soon — the bullish structure remains intact for further growth."

Parshwa Turakhiya, analyst, views Novartis as caught in a short-term tug-of-war between buyers and sellers. The price hovers near daily lows after a gap-down open, and momentum readings give no clear direction for immediate action. He notes that swing traders may find setups if the price challenges $144.38 or $149.00 levels in coming sessions. "Patience is key here — I see the next breakout from consolidation as a chance to catch sentiment-driven moves."

Mixed momentum as short-term selling meets long-term support

Novartis is trading below both the 20-day moving average ($149.61) and 50-day moving average ($149.08), but remains above the 200-day moving average ($142.14). This structure reflects short- and medium-term seller pressure with long-term trend support remaining intact; the nearest dynamic resistance is around the $149 level (MA-20 and Ichimoku Kijun), with support near $142 (MA-200). Momentum readings are mixed: the Moving Average Convergence Divergence (MACD) signals a buy on daily charts, but the Average Directional Index (ADX) remains weak around 10.9, indicating limited trend strength. The Relative Strength Index (RSI) is neutral to slightly positive, yet the Stochastic RSI points to overbought daily conditions and oversold on lower time frames, echoing the Commodity Channel Index (CCI) which is moderately neutral. Bull/Bear Power (BBP) suggests buyer dominance overall, but also flags an overbought reading. The Awesome Oscillator supports ongoing bullish structure on the daily chart. Novartis fell $3.50 (2.32%) today with a downside opening gap (about $1.18), now trading near the daily low. Intraday volatility stands at 2.04%, and the tone reflects clear downward pressure after the open, with momentum oscillators sending divergent signals against continued weakness.

Source of Data: NVS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.